Imaging essential tremor

Ioannis U. Isaias, Giorgio Marotta, Shigeki Hirano, Margherita Canesi, Riccardo Benti, Andrea Righini, Chengke Tang, Roberto Cilia, Gianni Pezzoli, David Eidelberg, Angelo Antonini

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β- (4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [ 99mTc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akinetic-rigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.

Original languageEnglish
Pages (from-to)679-686
Number of pages8
JournalMovement Disorders
Volume25
Issue number6
DOIs
Publication statusPublished - Apr 30 2010

Fingerprint

Essential Tremor
Parkinson Disease
Dopamine Plasma Membrane Transport Proteins
Caudate Nucleus
Tremor
Single-Photon Emission-Computed Tomography
Corpus Striatum
Spatial Analysis
Putamen
Discriminant Analysis
Photons
Tomography

Keywords

  • Essential tremor
  • SPECT

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Isaias, I. U., Marotta, G., Hirano, S., Canesi, M., Benti, R., Righini, A., ... Antonini, A. (2010). Imaging essential tremor. Movement Disorders, 25(6), 679-686. https://doi.org/10.1002/mds.22870

Imaging essential tremor. / Isaias, Ioannis U.; Marotta, Giorgio; Hirano, Shigeki; Canesi, Margherita; Benti, Riccardo; Righini, Andrea; Tang, Chengke; Cilia, Roberto; Pezzoli, Gianni; Eidelberg, David; Antonini, Angelo.

In: Movement Disorders, Vol. 25, No. 6, 30.04.2010, p. 679-686.

Research output: Contribution to journalArticle

Isaias, IU, Marotta, G, Hirano, S, Canesi, M, Benti, R, Righini, A, Tang, C, Cilia, R, Pezzoli, G, Eidelberg, D & Antonini, A 2010, 'Imaging essential tremor', Movement Disorders, vol. 25, no. 6, pp. 679-686. https://doi.org/10.1002/mds.22870
Isaias IU, Marotta G, Hirano S, Canesi M, Benti R, Righini A et al. Imaging essential tremor. Movement Disorders. 2010 Apr 30;25(6):679-686. https://doi.org/10.1002/mds.22870
Isaias, Ioannis U. ; Marotta, Giorgio ; Hirano, Shigeki ; Canesi, Margherita ; Benti, Riccardo ; Righini, Andrea ; Tang, Chengke ; Cilia, Roberto ; Pezzoli, Gianni ; Eidelberg, David ; Antonini, Angelo. / Imaging essential tremor. In: Movement Disorders. 2010 ; Vol. 25, No. 6. pp. 679-686.
@article{647f052b9ade4a7c821452c65682f769,
title = "Imaging essential tremor",
abstract = "To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β- (4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [ 99mTc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akinetic-rigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3{\%} in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30{\%} (first scan) and 5{\%} (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.",
keywords = "Essential tremor, SPECT",
author = "Isaias, {Ioannis U.} and Giorgio Marotta and Shigeki Hirano and Margherita Canesi and Riccardo Benti and Andrea Righini and Chengke Tang and Roberto Cilia and Gianni Pezzoli and David Eidelberg and Angelo Antonini",
year = "2010",
month = "4",
day = "30",
doi = "10.1002/mds.22870",
language = "English",
volume = "25",
pages = "679--686",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Imaging essential tremor

AU - Isaias, Ioannis U.

AU - Marotta, Giorgio

AU - Hirano, Shigeki

AU - Canesi, Margherita

AU - Benti, Riccardo

AU - Righini, Andrea

AU - Tang, Chengke

AU - Cilia, Roberto

AU - Pezzoli, Gianni

AU - Eidelberg, David

AU - Antonini, Angelo

PY - 2010/4/30

Y1 - 2010/4/30

N2 - To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β- (4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [ 99mTc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akinetic-rigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.

AB - To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β- (4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [ 99mTc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akinetic-rigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.

KW - Essential tremor

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=77951770621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951770621&partnerID=8YFLogxK

U2 - 10.1002/mds.22870

DO - 10.1002/mds.22870

M3 - Article

C2 - 20437537

AN - SCOPUS:77951770621

VL - 25

SP - 679

EP - 686

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 6

ER -